Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ0W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,062
Award facts
- Contract value 100% obligated
- $21,061.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,061.78 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections (2 mL units). This firm fixed-price delivery order, issued on January 15, 2026, with an ultimate completion date of January 16, 2026, represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Cosentyx is a biologic immunosuppressant used in treating inflammatory conditions, reflecting the breadth of specialty pharmaceuticals distributed through this contract vehicle.
Quick answers
Who was awarded contract SPE2DR26FJJ0W?
SPE2DR26FJJ0W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FJJ0W worth?
The government has obligated $21,062 on SPE2DR26FJJ0W.
Is contract SPE2DR26FJJ0W an order under another contract?
Yes. SPE2DR26FJJ0W is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ0W competed?
The extent of competition for SPE2DR26FJJ0W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award